Literature DB >> 10653482

Antioxidants and herbal extracts protect HT-4 neuronal cells against glutamate-induced cytotoxicity.

M S Kobayashi1, D Han, L Packer.   

Abstract

Antioxidant therapy has been shown to be beneficial in neurological disorders including Alzheimer's disease and cerebral ischemia. Glutamate-induced cytotoxicity in HT-4 neuronal cells has been previously demonstrated to be due to oxidative stress caused by depletion of cellular glutathione (GSH). The present study demonstrates that a wide variety of antioxidants inhibit glutamate-induced cytotoxicity in HT-4 neuronal cells. Low concentrations of alpha-tocopherol and its analogs were highly effective in protecting neuronal cells against cytotoxicity. Purified flavonoids and herbal extracts of Gingko biloba (EGb 761) and French maritime pine bark (Pycnogenol) were also effective. We have previously shown that pro-glutathione agents can spare GSH and protect cells from glutamate insult in a C6 glial cell model. The protective effects of nonthiol-based antioxidants tested in the HT-4 line were not mediated via GSH level modulation. In contrast, protective effects of thiol-based pro-glutathione agents alpha-lipoic acid (LA) and N-acetyl cysteine (NAC) corresponded with a sparing effect on GSH levels in glutamate-treated HT-4 cells. Glutamate-induced cytotoxicity in HT-4 cells is a useful model system for testing compounds or mixtures for antioxidant activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10653482     DOI: 10.1080/10715760000300121

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  13 in total

1.  Cognitive assessment of pycnogenol therapy following traumatic brain injury.

Authors:  Stephen W Scheff; Kelly N Roberts
Journal:  Neurosci Lett       Date:  2016-10-11       Impact factor: 3.046

2.  Neuroprotective effect of Pycnogenol® following traumatic brain injury.

Authors:  Stephen W Scheff; Mubeen A Ansari; Kelly N Roberts
Journal:  Exp Neurol       Date:  2012-10-08       Impact factor: 5.330

3.  Protective effect of Pycnogenol in human neuroblastoma SH-SY5Y cells following acrolein-induced cytotoxicity.

Authors:  Mubeen A Ansari; Jeffrey N Keller; Stephen W Scheff
Journal:  Free Radic Biol Med       Date:  2008-09-09       Impact factor: 7.376

4.  Pycnogenol protects CA3-CA1 synaptic function in a rat model of traumatic brain injury.

Authors:  Christopher M Norris; Pradoldej Sompol; Kelly N Roberts; Mubeen Ansari; Stephen W Scheff
Journal:  Exp Neurol       Date:  2015-11-29       Impact factor: 5.330

5.  A randomized controlled trial investigating the effect of Pycnogenol and Bacopa CDRI08 herbal medicines on cognitive, cardiovascular, and biochemical functioning in cognitively healthy elderly people: the Australian Research Council Longevity Intervention (ARCLI) study protocol (ANZCTR12611000487910).

Authors:  Con K Stough; Matthew P Pase; Vanessa Cropley; Stephen Myers; Karen Nolidin; Rebecca King; David Camfield; Keith Wesnes; Andrew Pipingas; Kevin Croft; Dennis Chang; Andrew B Scholey
Journal:  Nutr J       Date:  2012-03-06       Impact factor: 3.271

6.  Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.

Authors:  Jong Woon Park; Hee Jung Kwon; Woo Seok Chung; Chan Yun Kim; Gong Je Seong
Journal:  Korean J Ophthalmol       Date:  2011-09-20

7.  Neural protection by naturopathic compounds-an example of tetramethylpyrazine from retina to brain.

Authors:  Zhiqun Tan
Journal:  J Ocul Biol Dis Infor       Date:  2009-07-14

8.  Neuromuscular electrical stimulation and dietary interventions to reduce oxidative stress in a secondary progressive multiple sclerosis patient leads to marked gains in function: a case report.

Authors:  David Reese; Ezzatolah T Shivapour; Terry L Wahls; Shauna D Dudley-Javoroski; Richard Shields
Journal:  Cases J       Date:  2009-08-10

9.  Erratum: Neural protection by naturopathic compounds-an example of tetramethylpyrazine from retina to brain.

Authors:  Zhiqun Tan
Journal:  J Ocul Biol Dis Infor       Date:  2009-09-01

Review 10.  Using the Oxytosis/Ferroptosis Pathway to Understand and Treat Age-Associated Neurodegenerative Diseases.

Authors:  Pamela Maher; Antonio Currais; David Schubert
Journal:  Cell Chem Biol       Date:  2020-11-10       Impact factor: 8.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.